Home> Announcements> International topics> Trilateral Cooperation (JPO-EPO-USPTO)> Trilateral Project 24.1-Biotechnology> Trilateral Project 24.1-Biotechnology 076
Main content starts here.
If the actual invention of the application is to be seen in the cloning of the cDNA encoding protein X and said cDNA is sufficiently disclosed in the application, for example by its nucleotide sequence, then claims to the subject matter of (a) to (f) would also appear to be enabled, because a person skilled in the art would normally be able to obtain these products and carry out these processes using common general knowledge as described in standard textbooks/manuals of genetic engineering.